Suchergebnisse - "Multicenter Study"

PubPharm (862)

1

Evolution of the Sarnat exam and association with 2-year outcomes in infants with moderate or severe hypoxic-ischaemic encephalopathy : a secondary analysis of the HEAL Trial

enthalten in: Archives of disease in childhood. Fetal and neonatal edition | 2024

von Mietzsch, U. | Kolnik, S. | Wood, T. | +29

2

Roxadustat reduces left ventricular mass index compared to rHuEPO in haemodialysis patients in a randomized controlled trial

enthalten in: Journal of internal medicine | 2024

von Tan, W. | Wang, X. | Sun, Y. | +13

3

Disease Course of Clinically Isolated Optic Neuritis

enthalten in: Neurology(R) neuroimmunology & neuroinflammation | 2024

von Küchlin, S. | Ihorst, G. | Heinrich, S. | +5

4

Treatment of refractory or relapsed myelodysplastic neoplasms with luspatercept : a multicenter Chinese study

enthalten in: Annals of hematology | 2023

von Zhang, Z. | Hu, Q. | Tang, X. | +7

5

Erythropoietin to treat anaemia in critical care patients : a multicentre feasibility study

enthalten in: Anaesthesia | 2023

von Léger, M. | Auchabie, J. | Ferrandière, M. | +4

CommentIn: Anaesthesia. 2023 Oct;78(10):1203-1205. - PMID 37450345

6

Comparative Study of Recombinant Human Erythropoietin (rhEPO) Products on CKD (Chronic Kidney Disease) Patients

enthalten in: Drug research | 2023

von Dwitanto, K. | Angginy, N. | Sutandar, W.

7

Subcutaneous C.E.R.A. for the Maintenance Treatment of Anemia in Pediatric Patients With CKD : A Phase 2, Open-Label, Single-Arm, Multicenter Study

enthalten in: American journal of kidney diseases : the official journal of the National Kidney Foundation | 2023

von Warady, B. | Meyer Reigner, S. | Tirodkar, C. | +1

8

Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome : Multicenter Real-Life Data

enthalten in: Turkish journal of haematology : official journal of Turkish Society of Haematology | 2023

von Aslaner Ak, M. | Gedük, A. | Acar, �. | +6

9

Not baseline but time-dependent erythropoiesis-stimulating agent responsiveness predicts cardiovascular disease in hemodialysis patients receiving epoetin beta pegol : A multicenter prospective PARAMOUNT-HD Study

enthalten in: International journal of cardiology | 2023

von Fujii, H. | Hamano, T. | Tsuchiya, K. | +7

CommentIn: Heart Lung Circ. 2023 Aug;32(8):e53-e54. - PMID 37673553

10

Biosimilar erythropoietin in anemia treatment (BEAT)-Efficacy and safety of a 1:1 dose conversion from EPREX® to EPIAO® in patients with end-stage renal disease on hemodialysis : A prospective, randomized, double blind, parallel group study

enthalten in: Medicine | 2022

von Miao, B. | Isachkina, A. | Shutov, E. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[87]